Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,725
Closed -$416K 41
2019
Q4
$416K Sell
1,725
-475
-22% -$105K 0.53% 64
2019
Q3
$426K Sell
2,200
-775
-26% -$149K 0.39% 71
2019
Q2
$548K Hold
2,975
0.41% 69
2019
Q1
$565K Hold
2,975
0.43% 66
2018
Q4
$579K Hold
2,975
0.51% 61
2018
Q3
$617K Sell
2,975
-25
-0.8% -$4.93K 0.46% 65
2018
Q2
$549K Sell
3,000
-100
-3% -$17.7K 0.44% 65
2018
Q1
$528K Hold
3,100
0.44% 66
2017
Q4
$539K Sell
3,100
-35
-1% -$6.19K 0.44% 68
2017
Q3
$585K Sell
3,135
-15
-0.5% -$2.66K 0.5% 62
2017
Q2
$543K Hold
3,150
0.49% 62
2017
Q1
$517K Sell
3,150
-100
-3% -$16.6K 0.46% 64
2016
Q4
$475K Hold
3,250
0.42% 64
2016
Q3
$542K Hold
3,250
0.51% 59
2016
Q2
$494K Hold
3,250
0.47% 58
2016
Q1
$487K Sell
3,250
-50
-2% -$7.43K 0.5% 57
2015
Q4
$536K Sell
3,300
-100
-3% -$15.7K 0.55% 57
2015
Q3
$470K Hold
3,400
0.51% 59
2015
Q2
$522K Sell
3,400
-50
-1% -$8.01K 0.5% 62
2015
Q1
$551K Hold
3,450
0.55% 59
2014
Q4
$550K Hold
3,450
0.54% 58
2014
Q3
$485K Hold
3,450
0.48% 60
2014
Q2
$408K Sell
3,450
-100
-3% -$11.6K 0.37% 68
2014
Q1
$438K Hold
3,550
0.45% 62
2013
Q4
$405K Buy
+3,550
New +$404K 0.42% 64

Other funds holding AMGN

Wheatland Advisors's AMGN Position: Q1 2020 in Review

Wheatland Advisors sold out of Amgen (AMGN) in Q1 2020, closing a stake of 1,725 shares — an estimated $416K sold.

Wheatland Advisors first reported a position in AMGN in Q4 2013 and held it in 25 quarters. The position peaked at $617K in Q3 2018. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Wheatland Advisors reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
  • Wheatland Advisors sold 1,725 Amgen shares in Q1 2020, an estimated $416K.
  • Wheatland Advisors first reported a position in Amgen in Q4 2013 and held it in 25 quarters.
  • Wheatland Advisors's Amgen position peaked at $617K in Q3 2018.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Wheatland Advisors's 13F filing for Q1 2020, filed 8 May 2020.